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ABSTRACT
STRUCTURAL STUDIES OF TRPV5 MODULATION
Edwin Carl Fluck III
Vera Moiseenkova-Bell

Calcium homeostasis is a highly regulated process in the body. Transient
receptor potential vanilloid 5 (TRPV5) is a calcium selective ion channel that is
responsible for the regulation of calcium reabsorption in the kidney. TRPV5 has been
shown to be the essential for maintaining this calcium homeostasis and is implicated in
disorders including hypercalciuria and kidney stone disease. However, little is known
about the structural basis for mechanisms of TRPV5 regulation. Therefore, we aimed to
address questions surrounding TRPV5 structure and regulation by solving cryo-electron
microscopy (cryo-EM) structures of TRPV5 under various conditions. Specifically, we
focused on regulation by low pH and phosphorylation by protein kinase A (PKA) that
inhibit and activate TRPV5 respectively. Employing cryo-EM, we were able to structurally
evaluate TRPV5 under several low pH conditions along with the activating phospholipid
phosphatidylinositol

4,5-bisphosphate

(PI(4,5)P2).

The

structures

resolved

conformational changes elicited by low pH conditions. Next, we solved the cryo-EM
structures of TRPV5 to investigate the effect of PKA phosphorylation. TRPV5 was
investigated using a phosphomimic mutation to simulate TRPV5 phosphorylation.
Overall, the phosphorylation had little effect on channel structure, but we found that
phosphorylation decreases calmodulin (CaM) mediated inactivation. These findings
provide a better picture of TRPV5 modulation and will be helpful in the development of
therapeutics aimed to address calcium centric pathologies.
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CHAPTER 1: INTRODUCTION

1.1 Introduction to TRPV5
TRP channels are polymodal ion channels that are relatively voltage insensitive,
but are sensitive to many other types of stimuli and are involved in a multitude of cellular
processes1. They are composed of six transmembrane domains and arrange into
tetrameric assemblies to form a central ion conducting pore1,2. TRP channels can be
further divided into subfamilies of more closely related channels. There are six
subfamilies: TRPC (canonical), TRPV (vanilloid), TRPP (polycystic), TRPM (melastatin),
TRPA (ankyrin), and TRPML (mucolipin)1. Transient receptor potential (TRP) channels
were first discovered in Drosophila when looking at photoreceptors3. It was found that
the transient receptor potential (trp) mutant gave flies a behavioral phenotype of
blindness under high intensity light which was confirmed by electroretinograms showing
a quick return to baseline under these conditions3. Therefore, homologous mammalian
proteins became known as TRP channels after the first member of this family1.
The TRPV subfamily is made up of 6 members which are different from other
TRP channels in their domain arrangement. The TRPV subfamily can further be divided
into two subgroups: thermoTRPV (TRPV1-4) and calcium selective TRPV channels
(TRPV5-6)1. TRPV1, the namesake of the TRPV subfamily, has been of interest
because of its heat sensitivity and activation by vanilloids, including capsaicin which is
found in chili peppers1. Because of its role in temperature sensation, work on TRPV1
has recently been awarded the 2021 Nobel Prize in Physiology4. All of the thermoTRPVs
have been shown to be both sensitive to high temperature and are relatively nonspecific
to cations1. However, TRPV5 and TRPV6 are insensitive to heat and vanilloids, but are
1

highly specific towards Ca2+ ions (PCa:PNa > 100), setting them apart from the rest of the
TRPV channels1,5. Additionally, TRPV5 protein sequence is about 30% identical with the
thermoTRPV channels, but about 80% identical with TRPV65. TRPV5 and TRPV6 are
the result of a gene duplication event, which explains their similarity in sequence and
function5. TRPV5 is found in the kidneys and is the critical calcium channel to maintain
calcium homeostasis.
Calcium is a very important ion in the body which is used for a variety of
functions including cell signaling, bone formation, and muscle contraction6. Therefore,
calcium concentration must be tightly regulated in order for proper function of the
nervous, cardiac, and muscular systems. The body accomplishes this through regulation
of processes in the intestine, bone and kidney6. The intestine regulates the absorption of
calcium from the diet into the body6. Bone stores calcium and is regulated to either
absorb or release calcium when required6. Finally, the kidney controls the renal excretion
and reabsorption of calcium6. All three systems are under the control of calciotropic
hormones parathyroid hormone (PTH) and vitamin D (1,25-dihydroxycholecalciferol
(1,25-(OH)2D3)) in order to tightly regulate calcium homeostasis6,7. Disruptions to these
hormones can result in hypercalcemia or hypocalcemia, defined as high or low levels of
ionic calcium in the blood. Hypercalcemia and hypocalcemia can be caused by
hyperparathyroidism, diabetes and some types of cancer8. Additionally, hypercalciuria,
or calcium wasting, characterized by excess calcium in the urine, can also occur when
calcium homeostasis is disrupted8. Hypercalciuria is a risk factor for the developing
nephrolithiasis, better known as kidney stone disease9.
The importance of TRPV5 in calcium homeostasis can be shown through TRPV5
knockout mice, that display hypercalciuria and calcium wasting7. While their serum
2

calcium level was unaffected due to compensatory activities in the intestine and bone,
their renal calcium excretion was sixfold higher than wild type even on a low calcium
diet7. Knockout mice also presented the phenotype of reduced bone thickness as a
result of calcium wasting7. Overall, these studies highlighted the importance of TRPV5 in
hypercalciuria, a risk factor for kidney stone disease.
It was also found that single-nucleotide polymorphisms (SNPs) of TRPV5 exist in
humans that affect TRPV5 activity and may play a role in calcium homeostasis. While
many SNPs were found in genetic studies, a few stuck out that directly affected TRPV5
activity. The SNP variation L530R was demonstrated to abolish calcium reabsorption via
TRPV5 and has also been shown to be implicated in the recurrence of kidney stones in
a founder population from Iceland10. Other SNP variations A563T and L712F had the
opposite affect and were only found within African subpopulations5. It was also
suggested that a connection exists between these SNPs and the following
characteristics: lowered urinary Ca2+ excretion, lower risk for kidney stones, and higher
bone mass5. Together, TRPV5 knockouts and SNPs exemplify its importance in calcium
homeostasis.
All TRP channels conduct cations through a central pore that spans the lipid
membrane. This is formed through a tetrameric channel assembly where the six
transmembrane helices (S1-S6) are arranged in a domain-swapped architecture such
that the S1-S4 voltage sensor-like domain (VSLD) associates with the S5-S6 pore
domain of the adjacent monomer11. The pore helix (PH) is located between the S5 and
S6 helices and forms the selectivity filter11. These are conserved structural features of
related TRP channels and holds true for TRPV subfamily and TRPV5. Among the TRPV
subfamily, several other domains are conserved and form structural features of the
3

intracellular domain. This includes the ankyrin repeat domain (ARD) which in TRPVs
contains 6 ankyrin repeats11. ARDs are known to mediate protein-protein interactions12.
The ARDs make contacts with the β-sheet region from the neighboring subunit to form
the skirt-like shape of the intracellular domain11. The ARDs are connected to the
transmembrane domain (TMD) via the N-linker which consists of the β-sheet region, a
helix-turn-helix motif and the pre-S1 helix11. The β-sheet region is made up of 2 β-sheets
from the N-linker and 1 β-sheet from the C-terminal domain11. Following the TMD is the
TRP domain which is found in all TRPC, TRPV, and TRPM channels11,13. Finally, a
relatively unstructured C-terminal domain (CTD) makes up the rest of the protein11. In
TRPV5, the TMD and TRP domain mediate phosphatidylinositol 4,5-bisphosphate
(PI(4,5)P2) activation, the C-terminal domain mediates TRPV5 sensitivity to protein
kinase A (PKA), and both the ARD and CTD are involved in calmodulin (CaM) binding
and inactivation of the channel14-17.

1.2 TRPV5 in the body
It has been shown that a key location to maintain calcium homeostasis is in the
kidney where TRPV5 located. The kidney functions to filter and discard waste from the
body by filtering blood and producing urine. The fundamental structure in the kidney that
produces urine is known as the nephron, which is a series of tubules surrounded by
blood vessels, allowing for different components to be reabsorbed back into the blood
from the tubular fluid. First in the nephron, the glomerulus must take a crude solution of
water, salts, and other components from the blood to make up the tubular fluid.
Subsequent tubules all work to reabsorb important nutrients, salts and water back into
the blood from the tubular fluid in a regulated manner. These include the proximal tubule
4

(PT), the thick ascending limb (TAL), the distal convoluted tubule (DCT), the connecting
tubule (CNT) and the collecting duct (CD). Going from the glomerulus to the collecting
duct, the tubular fluid becomes filtered into urine. 99% of all calcium that enters the
nephron is reabsorbed along its tubules and the average person will only excrete about
200 mg per day21. 60% of this total calcium reabsorption along the nephron occurs by
passive transport in the PT and is coupled to the transport of water and sodium21.
Another 15% of calcium is reabsorbed in the TAL in a paracellular manner21. Finally,
about 10-15% of calcium is absorbed by active transport in the DCT and CNT where
reabsorption is fine tuned21.
TRPV5 is primarily expressed within the distal convoluted tubule of the kidney
nephron. TRPV5 was first identified with its close homolog TRPV6 in 2001 through a
genomic study18. This study also examined their mRNA expression in the small intestine,
kidney, and placenta18. Later renamed to TRPV5, they found that ECaC1, encoded by
CaT2 gene, was primarily expressed in the kidney18. TRPV6 was found to be more
broadly expressed but plays a role in intestinal absorption of calcium18,19. In further
studies, TRPV5 was found to be localized to the apical membrane bordering the tubular
fluid15. The Ca2+ ions from the tubular fluid flow across the membrane through TRPV5’s
ion conducting pore into the cell down its concentration gradient20. Inside the cell, Ca2+ is
then sequestered by calbindin-D28K, a calcium binding protein, to lower the intracellular
Ca2+ concentration and maintain the concentration gradient (Figure 1.1)20. Calcium is
then transported across the basolateral membrane into the blood through the
coordination of the sodium-calcium exchanger 1 (NCX1) and the plasma membrane
Ca2+ ATPase 1b (PMCA1b) (Figure 1.1)20. However, the fine-tuning of calcium
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reabsorption occurs through TRPV5 which is tightly regulated, and dysfunction can lead
to calcium disorders.
Kidney stones are accumulations of precipitated salts in the kidney22. In the
United States, about 5% of women and 12% of men will develop kidney stones in their
lifetime22. They can cause severe pain and can also cause damage to the kidney.
Additionally, individuals that have previously had a kidney stone have a 50% chance of
developing another within 7 years23. Therefore, it would be advantageous to develop
preventative therapies to avoid kidney stone reoccurrence. Kidney stones can be formed
from several major types of salts including calcium oxalate, calcium phosphate, struvite,
and uric acid22. About 80% of all kidney stones are formed when calcium salts
precipitate as a result of excessive calcium excretion22. Current treatments target indirect
mechanisms to regulate calcium reabsorption.

1.3 TRPV5 modulation
TRPV5 has many known modulators that work to regulate the channel and its
transport of calcium into the cell. Several endogenous modulators of TRPV5 found in the
cell are PI(4,5)P2, CaM, and PKA (Figure 1.1)17,24-26. Together these components work to
maintain the balance of calcium being reabsorbed in the kidney. TRPV5 is bound to
endogenous PI(4,5)P2 in the membrane which stabilizes the channel in an open, calcium
conducting state25. Once enough calcium has entered the cell, TRPV5 must be
inactivated. This is accomplished through a CaM-mediated pathway triggered by calcium
binding24. Activated CaM associates with TRPV5 and sterically blocks the ion conducting
pore16,27. PI(4,5)P2 removal is another calcium dependent inactivation mechanism that
6

activated by phospholipase C (PLC)28. Finally, PTH can be released to signal for more
calcium reabsorption via TRPV529. When the PTH receptor becomes activated as a
result of this signaling, it then activates the PKA pathway by generating cyclic-AMP
(cAMP) through adenylyl cyclase (AC)29,30. PKA exists as a heterotetramer of 2
regulatory and 2 catalytic subunits in the inactive state31. When cAMP binds to the
regulatory subunits of PKA, the catalytic subunits of PKA (PKAcat) are released from the
holoenzyme to phosphorylate targets, in this case, TRPV530,31. It has been found that
PKA phosphorylation of TRPV5 residue T709 is responsible for increased single-channel
activity30. Interestingly, this site overlaps with the CaM binding site and it has been
proposed that phosphorylation disrupts and prevents the CaM binding and inactivation of
TRPV5, allowing for more calcium reabsorption24.

Figure 1.1. TRPV5 modulation. A schematic diagram highlighting TRPV5 function in
calcium transport. Modulators affect TRPV5 activity directly or through signaling
pathways as shown. Created with BioRender.com.
7

The cellular environment also plays a role in regulation of TRPV5. It was found
that chronic metabolic acidosis can lead to hypercalciuria in patients32. Under this
condition, the pH of the urine can reach as low as pH 4.4 and has been shown to directly
inhibit TRPV533,34. Conversely, high pH has been shown to activate TRPV535. Therefore,
low pH of the environment is a direct pathophysiological modulator. Several
electrophysiological studies have confirmed the identities of titratable pH sensors on
both intra- and extracellular sides of the membrane at K607 and E522, respectively36-39.
One study on inhibition by intracellular pH also revealed a sub-conductance state
between open and closed states under low pH conditions36. The mechanism of action for
both of these sensors was proposed to be a conformational change that induces pore
closing38. Additionally, it was proposed that acidification on either side enhanced the
inhibition by low pH on the opposite side38. For example, lowering the external pH
causes the pKa for internal pH regulation to increase38. This suggested the pH from both
sides is cross-regulated at the same gate38.
Aside from endogenous modulators, several exogenous modulators of TRPV5
have also been studied. These consist of small molecules that bind TRPV5 to inhibit the
channel. One of the first studied of these small molecule inhibitors is ruthenium red, a
stain and pore blocker of many ion channels40. Another small molecule, econazole, is an
antifungal drug that has been found to inhibit TRPV5 and TRPV6 with an IC50 in the low
micromolar range40-42. However, its use is limited due to its ability to inhibit many other
calcium channels and its poor solubility in water. However, econazole was proposed to
bind in the vanilloid binding pocket, where TRPV1 binds capsaicin and other vanilloids41.
This binding pocket was probed using structure-based virtual screening (SBVS) to
develop new small molecule modulators of TRPV543. Using this computational screen
8

and investigating hits with electrophysiology, ZINC9155420 was found to be a potent
inhibitor of TRPV5 and TRPV6 also in the low micromolar range43. However, a specific
inhibitor for TRPV5 was able to be found by derivatizing this original compound.
ZINC17988990 was found to inhibit TRPV5 in the nanomolar range but did not affect
TRPV6 activity making it the first specific inhibitor of TRPV543. To date, no small
molecule activators of TRPV5 have been found.

1.4 Techniques
Cryo-electron microscopy (cryo-EM) is a technique that is under constant
improvement through the development of new technologies and methods that are
capable of generating high-resolution protein structure. Pioneers in the field have made
advancements leading to a “Resolution Revolution” of near-atomic resolution structures
and won the 2017 Nobel Prize in Chemistry44. Increasing accessibility and highthroughput design have also contributed to its popularity. Recent years have brought
technologies including advanced transmission electron microscopes, energy filters, new
direct electron detector (DED) cameras, automated cryo-EM grid preparation, grid
autoloaders, data collection protocols that can collect thousands of images per day, and
intuitive refinement software.
Typical single particle cryo-EM consists of imaging biological samples, that have
been frozen at cryogenic temperatures using liquid ethane and are embedded in vitreous
ice. In many cases, purified proteins, nucleic acids, and protein complexes are examined
using this technique. Images of these biological samples can then be used to generate a
reconstruction of the target of interest through computational techniques. Typically,
9

purified sample is frozen on grids with a thin support layer allowing for the particles to be
embedded in a thin, vitreous layer of ice. Because the particles can move freely in
solution, they are oriented in different positions after vitrification which can be seen in the
images and is essential for reconstruction. This approach opened the door to study
samples that would otherwise be difficult to study by other structural methods. By solving
structures under different conditions, important conformational changes can be
distinguished to explain function. Newly developed softwares are also now able to sort
and even visualize intrinsic flexibility in a sample, allowing analysis of relevant
movements of the sample from a single dataset45.
While cryo-EM has provided some major benefits towards solving protein
structures of difficult samples, it is still limited in certain aspects. For example, cryo-EM
works best on larger particles, and can be difficult to analyze smaller particles below
100kDa. However, new technologies like the phase plate have been developed to
attempt address this limitation. Cryo-EM can now be used on many types of samples
ranging from smaller proteins, membrane proteins, larger protein complexes, and even
protein filaments, all of which can be difficult or impossible to crystallize. It is also
advantageous because it can accommodate full-length versions of proteins with flexible
regions as opposed to X-ray crystallography which typically requires a truncation of
flexible regions. Overall, the advantages of cryo-EM make it an optimal method for the
structural analysis of membrane proteins in general, and subsequently, for TRPV5 as
well.
Electrophysiology is another powerful technique that is used in ion channel
research. It allows for the examination of channels and transporters in cells. By
monitoring the current across a membrane, properties of an ion channel can be
10

evaluated. Electrophysiology requires cells to express the channel of interest and a
patch onto a membrane using a glass pipette. One system commonly used for
expression and measurement of these channels is in the oocytes of the South African
frog Xenopus laevis. These large cells allow for easy microinjection of cDNA or mRNA
encoding the exogenous protein of interest46. Several configurations of this setup allow
for variations of measurements to answer specific questions. Two electrode voltage
clamp allows for the whole-cell measurement of ion channels in larger cells such as
oocytes. In this setup, one electrode applies a membrane potential (Vm) and the other
electrode measures the membrane potential to observe differences made by the channel
of interest. However, oocytes can also be used to perform inside-out and outside-out
patch clamp experiments as well where a section of the membrane containing the
channel is isolated in the glass pipette. Channels can also be expressed in other cell
types, such as human embryonic kidney (HEK) cells. These cells can also be used in
whole cell configuration, and both inside-out and outside-out configurations. Using
different sized glass pipettes can alter the size of the patch and with small enough
pipettes, single channel activities can be evaluated. Patches can be manipulated using
perfusion of different solutions to probe the channel. This allows for the identification of
regulatory mechanisms, drugs, and states of the channel.

1.5 Scope of work
The lack of structural information about TRPV5 gating mechanisms motivated
these studies. Some structural information on TRPV5 with PI(4,5)P2, CaM and select
small molecule inhibitors have been examined in previous studies, however, little
structural information is known about TRPV5 modulation by low pH or PKA-mediated
11

phosphorylation. The goal of this thesis was to build upon previous studies and
determine additional structural mechanisms of TRPV5 modulation.
In Chapter 2, I report my thesis work on the molecular detail of TRPV5
modulation by pH and PKA. Using cryo-EM structural determination, I solved TRPV5
under both of these conditions for the first time. TRPV5 under the effect of low pH
revealed an inhibitory effect on the channel by inducing structural changes and driving
the dissociation of PI(4,5)P2. We also investigated the phosphorylation of TRPV5 by
PKA to give insights into how PKA phosphorylation increases TRPV5 activity. We found
that while little structural change occurs upon phosphorylation, its main effect was to
prevent CaM binding. Inhibiting this mechanism of CaM-mediated inactivation then
causes more TRPV5 activity.
I then summarize the results of my work and provide context to the field in
Chapter 3. The significance and impacts of this research are explored. I also discuss
future directions to address additional questions regarding TRPV5.
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2.1 Summary
Transient Receptor Potential Vanilloid 5 (TRPV5) is a kidney specific Ca2+ selective
ion channel that plays a key role in Ca2+ homeostasis. The basal activity of TRPV5 is
determined through the balance between activation by phosphatidylinositol 4,5bisphosphate (PI(4,5)P2) and inhibition by Ca2+ bound calmodulin (CaM). Parathyroid
hormone (PTH), the key extrinsic regulator of Ca2+ homeostasis, increases channel
activity via Protein Kinase A (PKA)-mediated phosphorylation. Metabolic acidosis leads
to reduced TRPV5 activity independent of PTH, causing hypercalciuria. Using cryo
electron microscopy (cryo-EM) we showed that low pH inhibits TRPV5 by precluding
PI(4,5)P2

activation. We captured several intermediate conformations at low pH,

revealing transition from open to closed state. Additionally, we demonstrated that
PI(4,5)P2 is the primary modulator of channel gating, yet PKA controls TRPV5 activity by
preventing CaM binding and channel inactivation. Our data provide detailed molecular
mechanisms for regulation of TRPV5 by two key extrinsic modulators, low pH and PKA.

Keywords
transient receptor potential channel; TRP channel; cryo-electron microscopy; cryo-EM;
calcium homeostasis; PI(4,5)P2; pH; protein kinase A; PKA; calmodulin; CaM
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2.2 Introduction
Calcium homeostasis is essential for survival and is accomplished through
coordination of functions in the intestine, bone, and kidney47,48. In the kidney, Transient
Receptor Potential Vanilloid 5 (TRPV5) is the key regulator of calcium homeostasis49. It
functions by reabsorbing calcium from the tubular fluid and facilitating its transport back
into the circulation48,50,51. Mice lacking TRPV5 displayed hypercalciuria and disruptions to
bones7. Furthermore, loss of function mutations of TRPV5 in humans are associated
with kidney stones10,52. Parathyroid hormone (PTH), the key regulator of Ca2+
homeostasis, increases Ca2+ reabsorption in the kidney by increasing TRPV5 activity via
Protein Kinase A (PKA)–mediated phosphorylation20,24,30,53.
Chronic metabolic acidosis is a condition that leads to increased calcium excretion in
the urine32. Urine pH can reach as low as pH 4.4 in some conditions and low pH has
been shown to inhibit the transport of calcium in the distal nephron33,34. TRPV5 is directly
inhibited by low pH and the channel was proposed to contain both intra- and extracellular titratable pH sensors, Lys607 and Glu52236,38,39,54. It has been shown that low
intracellular pH decreases the open probability of the channel (Po)36. While functional
studies have revealed aspects of TRPV5 modulation by pH36,38,39,54, limited information
can be deduced about the structural mechanisms of the pH regulation of TRPV5.
TRPV5 shows constitutive activity, which is maintained by activation of its
endogenous co-factor phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2)25. TRPV5 also
undergoes Ca2+-induced inactivation, which is mediated by calmodulin (CaM) binding to
the channel24. The precise balance between PI(4,5)P2 activation and CaM inhibition
determines the basal activity of the channel55,56. Recently, TRPV5 structural studies in
the presence of CaM and PI(4,5)P2 revealed how this channel’s constitutive activity is
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accomplished. PI(4,5)P2 binding is coordinated by the four positively charged residues
located between the N-linker (Arg302, Arg305), S4-S5 linker (Lys484), and the S6 helix
(Arg584) of the channel, which induces TRPV5 conformational rearrangements to dilate
the pore in order to open the channel16. Calcium-activated CaM binds to the distal Cterminus (residues His699-Thr709) of the channel and sterically blocks the ion
conducting pore at Trp583 through a cation-π interaction with Lys116 on the C-lobe of
CaM16,27. However, the structural basis of the regulation of the channel by extrinsic
physiological and pathophysiological regulators such as PKA and low pH, and their
relationship to PI(4,5)P2 and CaM has not been studied.
Here, we used cryo-electron microscopy (cryo-EM) to gain structural insights into the
mechanism of TRPV5 modulation by low pH and PKA and their relationship the intrinsic
regulators PI(4,5)P2 and CaM. Our results show that low pH precludes TRPV5
interaction with PI(4,5)P2 and revealed unique synergetic effects of pH and the lipid cofactor on channel gating. Moreover, our results suggested that PKA phosphorylation is
another modulator of channel activity that interplays with PI(4,5)P2 and CaM modulation.
These data provide understanding of TRPV5 regulation in the kidney by two key
physiological and pathophysiological regulators, which may pave the road to
development of better therapeutics for kidney stone disease.
2.3 Results
TRPV5 pH modulation
To understand how TRPV5 is modulated by pH, first we measured TRPV5 activity in
Xenopus oocytes using two electrode voltage clamp (TEVC) recordings. We measured
inwardly rectifying monovalent TRPV5 currents upon application of solutions with
different pH values. Figure 2.1A shows that lower extracellular pH decreases TRPV5
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current amplitudes, which is consistent with earlier whole cell patch clamp experiments
in CHO cells39.
Following our electrophysiological results, we investigated the effect of low pH on
TRPV5 at the structural level using high-resolution cryo-EM. Full-length rabbit TRPV5
was reconstituted into nanodiscs and the structure of the apo TRPV5 at pH 8.0
(TRPV5pH8) was determined using cryoSPARC at 3.2 Å resolution (Fig. 2.1B-C, Fig.
2.S1, Table 2.1). To determine TRPV5 structures at lower pH, TRPV5 was first
reconstituted into nanodiscs at pH 8.0 and then the buffer pH was adjusted to pH 5.0 or
to pH 6.0, followed by 5 minutes of incubation before the sample was frozen. Data were
also processed using cryoSPARC and produced TRPV5pH6 structure at 3 Å resolution
and TRPV5pH5 structure at 3.7 Å resolution (Fig. 2.1B-C, Fig. 2.S1, Table 2.1). The
domain architectures of each of these newly solved TRPV5 structures in nanodiscs were
similar to previously reported TRPV5 structures16,27,41,43 (Fig. 2.S2).
To compare these three new TRPV5 structures (TRPV5pH8, TRPV5pH6, TRPV5pH5),
we aligned them on the tetrameric pore (Lys490-Phe512 and Phe553-Ala586) of each
channel. Upon comparison (Fig. 2.1B-G, Fig. 2.S3A), we noted that TRPV5pH6 and
TRPV5pH5 adopted a different conformation from TRPV5pH8 (Fig. 2.1B-G). While the pore
radius at Ile575 of TRPV5pH6 (1.2 Å) and TRPV5pH5 (0.7 Å) were comparable to
TRPV5pH8 (0.9 Å) (Fig. 2.S3A), in both low pH structures one difference could be seen
clearly in the new position of Trp583 at the bottom of the channel pore that narrowed the
ion permeation pathway (Fig. 2.1B-C, Fig. 2.S3A). In addition to changes observed in
the pore domain between TRPV5pH8, TRPV5pH6 and TRPV5pH5 (Fig. 2.1B-C), we noted
that the ankyrin repeat domain (ARD) adopted a slightly different conformation in the
TRPV5pH6 and TRPV5pH5 structures. At low pH, the ARDs of TRPV5 moved upward by
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2.2Å towards the transmembrane domain (TMD) compared to TRPV5pH8 (Fig. 2.1F) and
slightly rotated (Fig. 2.1G). These conformational changes in the channel seem to be
initiated by the formation of a salt bridge network near the proposed intracellular pH
sensor Lys607 (Fig. 2.1D, Fig. 2.S4A-B). A salt bridge forms between amino acid
residues of opposite charges via an electrostatic interaction within 4Å distance57.
Particularly, in the TRPV5pH5 and TRPV5pH6 structures, Arg606 and Lys607 both interact
with Asp406 and form two salt bridges, that could not be observed in the TRPV5pH8
structure (Fig. 2.1D, Fig. 2.S4A-B). Moreover, the formation of the salt bridge between
Arg409 and Glu294 may be also stabilize these newly observed states at low pH (Fig.
2.1D, Fig. 2.S4A-B). Together, formation of these three salt bridges between TRP helix,
S2-S3 linker, and N-linker locked the channel into this new low pH state (Fig. 2.1).
Lowering the pH did not have an effect on the proposed extracellular pH sensor Glu522,
(Fig. 2.1E). While we identified the molecular mechanism of pH effect on the proposed
intracellular pH sensor near Lys607 in the channel, the experiments could not
demonstrate how pH exactly inhibited the channel, as all three structures are essentially
in a closed state.
We hypothesized that since the key endogenous activator of TRPV5 is PI(4,5)P225,
its addition to nanodisc-reconstituted TRPV5 and lowering of the pH would allow us to
better recapitulate the native environment of TRPV5 and the effect of pH on channel
gating. In order to investigate this effect, we determined the structure of TRPV5 at pH
6.0 in the presence of PI(4,5)P2 in two conditions (Fig. 2.2, Fig. 2.S5, Table 2.1). We
chose to pursue pH 6.0 for these studies since sample quality significantly diminished at
pH 5.0. In condition 1, nanodisc-reconstituted TRPV5 was incubated with PI(4,5)P2 at pH
8.0 first as we reported previously16, and then the sample pH was adjusted to pH 6.0 for
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5 minutes before freezing. We determined two structures from condition 1: the first
structure at 2.7 Å resolution contained a clear PI(4,5)P2 density, therefore we named this
structure TRPV5pH6+PIP2-state1 (Fig. 2.2B,G, Fig. 2.3B,G,K,O, Fig. 2.S5). A second
structure at 2.8 Å resolution did not contain a PI(4,5)P2 density, and we named this
structure TRPV5pH6-state2 (Fig. 2.2C,H, Fig. 2.S5). These two structures had a similar
number of particles (Fig. 2.2, Fig. 2.S5, Table 2.1).
In condition 2, the sample was first adjusted to pH 6.0 again for 5 minutes before
incubation with PI(4,5)P2 as previously described16 and then frozen on grids. Condition 2
revealed one structure without a PI(4,5)P2 density, TRPV5pH6-state3, at 2.6 Å resolution
(Fig. 2.2D,I, Fig. 2.S5, Table 2.1).
While all three structures were resolved at similar resolutions, the PI(4,5)P2 density
was only observed in the TRPV5pH6+PIP2-state1 structure (Fig. 2.3G,K,O), where the protein
was at pH 6.0 for only a short period of time before freezing. The structure of
TRPV5pH6+PIP2-state1 resembled our previously determined TRPV5 PI(4,5)P2 bound
structure at pH 8.0 referred as TRPV5pH8+PIP2 (PDB 6DMU)16 (Fig. 2.2A,F, Fig.
2.3A,F,J,N). TRPV5pH6+PIP2-state1 had PI(4,5)P2 fully engaging with the channel (Fig. 2.3G),
the pore radius at Ile575 in the TRPV5pH6+PIP2-state1 structure was around 2.7 Å while in
TRPV5pH8+PIP2 it was around 3.3 Å (Fig. 2.S3A). Interestingly, the Asp542 in the
TRPV5pH6+PIP2-state1 was facing the pore vestibule which differs from previously observed
conformation of Asp542 in TRPV5pH8+PIP2 (Fig. 2.2A-B,E, Fig. 2.S3A). Asp542 has been
shown to adopt two conformations which is consistent with its dynamic nature and the
upward conformation has only been noted upon PI(4,5)P2 binding at pH 8.016. Moreover,
the salt bridge network in the TRPV5pH6+PIP2-state1 between Lys607 and Asp406, and
between Arg409 and Glu294 were starting to form (Fig. 2.2G, Fig. 2.S4C-D).
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The TRPV5pH6-state2 structure did not have bound PI(4,5)P2, the pore radius at Ile575
was around 1.1 Å and all salt bridges at Arg606, Lys607 and Asp406, and at Arg409 and
Glu294 were almost fully formed, similarly observed in TRPV5pH6 (Fig. 2.2C,E,H, Fig.
2.S4C-D). To understand how low pH inhibits TRPV5 after PI(4,5)P2 activation, we again
aligned to the tetrameric pore and made comparisons between TRPV5pH8+PIP2,
TRPV5pH6+PIP2-state1 and TRPV5pH6-state2 structures. The formation of salt bridges near the
proposed intracellular pH sensor Lys607 leads to significant conformational changes in
the TRPV5pH6+PIP2-state1 compared to the TRPV5pH8+PIP2. In TRPV5pH6+PIP2-state1 the ARD
shifted upward 4.8 Å and rotates by 3.5°, which was also accompanied by overall
movements of 2.2 Å in the S1-S4 bundle, 1.6 Å in the S4-S5 linker, 1.1 Å in S5, and a
2.0 Å upward movement at the beginning of the TRP helix (Fig. 2.4A-B). Also, in
TRPV5pH6+PIP2-state1, the S6 helix moved 0.9 Å to constrict the pore but was otherwise in a
similar position to TRPV5pH8+PIP2. The conformational changes seen in the TRPV5pH6+PIP2state1

structure seemed to be on the transition to the TRPV5pH6-state2 structure which had

the same, yet larger movements compared to TRPV5pH8+PIP2. In TRPV5pH6-state2 the ARD
shifted upward 4.8 Å and rotates by 6.5°, which was also accompanied by an overall
movement of 2.4 Å in the S1-S4 bundle, 2.2 Å in the S4-S5 linker, 1.7 Å in S5, and a 5.0
Å upward movement at the beginning of TRP helix. Also, in TRPV5pH6-state2, the S6 helix
moved by 2.3 Å to constrict the pore in a similar position to TRPV5pH6, but with Trp583 in
a position similar to TRPV5pH8 (Fig. 2.1C, Fig. 2.2C, Fig. 2.4A, Fig. 2.S3A).
While the structures of the channel found in condition 1 indicated that low pH
induced conformational changes involved in closing the channel, our condition 2, where
PI(4,5)P2 was added to the channel protein already at pH 6.0, probed how low pH affects
PI(4,5)P2 interaction with the channel. First, we compared TRPV5pH6-state3 and TRPV5pH6
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(Fig. 2.4C-D) and noticed that these structures are very similar (Fig. 2.4C-D). Yet, the
notable difference between TRPV5pH6-state3 and TRPV5pH6 is the position of Ile575 that
allowed the TRPV5pH6-state3 pore to adopt a wider radius of 2.1 Å compared to the
TRPV5pH6 structure at 1.2 Å, confirmed by the model fit to the density (Fig. 2.1B-C, Fig.
2.2D-E, Fig. 2.S3A). Both the TRPV5pH6-state3 and TRPV5pH6 structures had similar
conformational changes compared to the TRPV5pH8+PIP2 structure including a 6.2 Å
upward shift and 5° rotation of the ARD, as well as overall movements of 2.3 Å in the S1S4 bundle, 1.9 Å in the S4-S5 linker, 1.5 Å in S5, 1.7 Å in S6, and a 4.6 Å upward
movement at the start of the TRP helix (Fig. 2.4C-D). Additionally, PI(4,5)P2 was not
resolved bound to the TRPV5pH6-state3 channel (Fig. 2.3H), and all key positivity charged
coordinating residues (Arg302, Arg305, Lys484, and Arg584) were not engaged at this
site suggesting that low pH prevents PI(4,5)P2 from binding (Fig. 2.3H,L). This was also
confirmed by calculating the electrostatic potential in the PI(4,5)P2 binding site which
revealed less positive charge and reduced binding pocket surface area in TRPV5pH6-state3
compared to TRPV5pH6+PIP2-state1 and TRPV5pH8+PIP2 (Fig. 2.3N-P). However, in condition
2, we captured TRPV5 in an intermediate, partially open conformation, suggesting
possible transient interactions with PI(4,5)P2 (Fig. 2.3C,E,H). We would like to note that
in both conditions, lowering the pH again did not have an effect on the extracellular pH
sensor Glu522 (Fig. 2.2J).
To test the functional importance of the salt bridge formation between the Lys607
and the Asp406 residues, we mutated the Asp406 residue to Ala (Asp406Ala). We found
that this mutation had a profound effect on inhibition by intracellular low pH. Fig. 2.4E-F
shows excised inside out patch clamp measurements after current rundown and
reactivation by diC8 PI(4,5)P2. Changing the pH of the perfusion solution from pH 7.4 to
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pH 6.4 inhibited wild type TRPV5 channel activity by 58.5 ± 6.4 %. The D406A mutant
on the other hand was not inhibited by pH 6.4, but rather its activity increased by 64.4 ±
11.3 %.
TRPV5 modulation by PKA
In order to investigate the effect of post-translational modification by PKA on
TRPV524,30, we first performed a phosphorylation assay to confirm that the purified
TRPV5 protein in detergent could be phosphorylated by the catalytic subunit of PKA
(PKAcat) (Fig. 2.S6A). Mass spectrometry confirmed that the Thr709 residue in TRPV5 is
phosphorylated in these in vitro conditions (see Methods). Next, we utilized cryo-EM
under the same experimental condition to solve the structure of the TRPV5 in the
presence of PKAcat (TRPV5PKA) at pH 8.0 (Fig. 2.S6B-F). Extensive computational
sorting was employed in cryoSPARC (see Methods, Table 2.1) and we consistently
noted that only one class contained an extra density in the ARD “skirt” in this dataset
(Fig. 2.S6G). Similar observations were made by our group when we solved the TRPV5
CaM-bound structure (Fig. 2.S6H). Thus, knowing that CaM and PKAcat both interact
with the distal C-terminus of the channel and involve Thr709 for its binding, we attributed
this density to the PKAcat (Fig. 2.S6G). The TRPV5PKA structure was resolved in C1
symmetry and only reached 4.5Å resolution, which did not allow us to determine atomic
details between PKAcat and the channel (Fig. 2.S6B-F). Efforts to resolve the TRPV5
structure in the presence of PKAcat to higher resolution and in better detail using all
currently available methods were not successful (see Methods). Therefore, we only
compared this structure with the CaM-bound TRPV5 by lowpass filtering to 10Å
resolution (Fig. 2.S6H). This comparison allowed to conclude that PKAcat likely interacts
with the distal C-terminus of the channel transiently, while CaM tightly binds the C22

terminus and pore of the channel, allowing the TRPV5-CaM structure to be resolved to
higher resolution (Fig. 2.S6G-H). This is not surprising, since the function of a kinase is
to phosphorylate its target, for which a stable interaction may not be necessary.
Next, due to the transient nature of the complex, we investigated the effect of PKA
phosphorylation specifically at the Thr709 residue. We made the Thr709Asp
phosphomimetic TRPV5 mutant to simulate PKA phosphorylation at this site, as it has
been implemented in previous functional studies24,30. In a cellular environment, TRPV5 is
exposed to both PI(4,5)P2 and PKA concurrently. To test our hypothesis on the interplay
between PI(4,5)P2 and phosphorylation on TRPV5 gating, we used cryo-EM to solve
TRPV5 Thr709Asp mutant (TRPV5T709D) structures with and without PI(4,5)P2.
Structures of TRPV5T709D and TRPV5T709D+PIP2 were solved to 2.8Å and 3.4Å resolution,
respectively (Fig. 2.S7, Table 2.1). The state of TRPV5T709D largely resembles TRPV5pH8
at the pore region (Fig. 2.5A-B); with minimal conformational changes at the ARDs
region of the channel (All-atom RMSD 1.08 for TRPV5T709D vs TRPV5pH8) (Fig. 2.5E-G).
On the other hand, the TRPV5T709D+PIP2 structure was captured at a new intermediate
conformation, different from the original fully open TRPV5pH8+PIP2 structure (Fig. 2.3).
Interestingly, it also differs from the newly obtained partially open intermediates
TRPV5pH6+PIP2-state1 and TRPV5pH6-state3 (Fig. 2.3).
In the TRPV5T709D+PIP2 structure PI(4,5)P2 was resolved at the same binding site as in
the TRPV5pH8+PIP2 structure and located between the N-linker, S2-S3 linker, S4-S5 linker,
and S6 helix (Fig. 2.3). Binding in this pocket induced the conformational changes
needed to open the lower gate, yet the pore radius measured at Ile575 in the
TRPV5T709D+PIP2 structure is around 2.4 Å compared to the fully open TRPV5pH8+PIP2
structure (around 3.3 Å) (Fig. 2.5E, Fig. 2.S3B). Additionally, Asp542 was resolved
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facing the pore vestibule due to the dynamic nature of the selectivity filter, differing from
the TRPV5pH8+PIP2 state (Fig. 2.5, Fig. 2.S3). Moreover, the channel underwent several
conformational changes that differ from the fully open TRPV5pH8+PIP2 (Fig. 2.5H-I). In
TRPV5T709D+PIP2 structure, the ARD shifts upward 5 Å and rotates by 3.5° compared to
TRPV5pH8+PIP2, which is also accompanied by an overall movement of 2.0 Å in the S1-S4
bundle, 1.5 Å in the S4-S5 linker, 1.0 Å in S5, and a 2.3 Å upward movement at the
beginning of the TRP helix (Fig. 2.5H-I). Interestingly, when we compare TRPV5pH8+PIP2
and TRPV5T709D+PIP2 structures, it became evident that Thr709Asp phosphomimetic
mutation is influencing the position of the ARDs in the TRPV5 structure, but not the
opening of the channel (Fig. 2.5H-I). It seemed that PI(4,5)P2 as the endogenous
modulator was predominantly responsible for stabilizing the open state of the TRPV5. To
further test this hypothesis, we measured wildtype and Thr709Asp TRPV5 activity in
excised inside-out patch clamp recordings. Run-down of currents following membrane
excision was observed in both wildtype and TRPV5 Thr709Asp mutant. This rundown is
typical of PI(4,5)P2 dependent ion channels, and is caused by dephosphorylation of
PI(4,5)P2 by lipid phosphatases in the patch membrane. Application of diC8 PI(4,5)P2 in
the perfusion restored channel activity for both Thr709Asp mutant and wild type TRPV5.
Since current amplitudes in excised patch recordings are highly variable between
oocytes, we normalized current amplitudes to those at 50 µM diC8 PI(4,5)P2. As shown
in Figure 2.5J-K, Thr709Asp mutation did not alter TRPV5 dependence on diC8 PI(4,5)P2
and different concentrations of diC8 PI(4,5)P2 evoked currents at comparable
magnitudes.
As indicated by previous studies the binding of CaM to the TRPV5 Thr709Asp
mutant is partially impaired as seen through pull down assays24. In order to further
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investigate the effect of Thr709 phosphorylation on channel gating, the interaction
between TRPV5 Thr709Asp mutant with CaM was further examined through cryo-EM
structural studies. Structural studies were performed on the nanodisc-reconstituted
TRPV5 Thr709Asp mutant incubated with CaM in the presence of calcium
(TRPV5T709D+CaM). Data processing revealed the TRPV5T709D+CaM structure at 3.0Å
resolution and no density that could be attributed to CaM. The TRPV5T709D+CaM structure
was identical to TRPV5pH8 and TRPV5T709D structures (Fig. 2.S6I-J, Fig. 2.S7, Table 2.1).
2.4 Discussion
TRPV5 is a highly selective calcium channel that is primarily expressed in the kidney
and plays an essential role in calcium reabsorption5,50,55. TRPV5 gating is tightly
regulated by numerous endogenous modulators to precisely control calcium
influx5,24,25,55. In this study, we have presented molecular details of interplay between
PI(4,5)P2, pH, CaM, and PKA phosphorylation on TRPV5 gating.
PI(4,5)P2 is a general regulator of many different ion channels including TRP
channels. For the majority of ion channels, PI(4,5)P2 acts as an obligate cofactor
necessary for channel activity58. Phosphoinositide regulation of TRP channels is more
complex in many cases, but for the vast majority of TRP channels PI(4,5)P2 acts as a
positive regulator59. Most TRP channels require additional factors to open, but TRPV5
and its close relative TRPV6 are opened by resting levels of PI(4,5)P2 alone59, making
them constitutively active. Thus, these channels are ideal model systems to understand
molecular mechanism of channel opening by this core regulator. Currently the only
published TRP channel structure where PI(4,5)P2 is resolved, and induces an open
conformation is our previously published TRPV5 structure at 4 Å resolution16. Here, we
determined two new structures of TRPV5 with PI(4,5)P2 at 2.8 Å for TRPV5pH6+PIP2-state1
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and at 3.4 Å for TRPV5T709D+PIP2. In both cases, we clearly resolved the PI(4,5)P2 density
in the previously proposed PI(4,5)P2 binding site16 and showed that addition of PI(4,5)P2
to the channel clearly produced conformational changes, which substantially increased
TRPV5 pore diameter compared to the structure without PI(4,5)P2. These results provide
a solid structural basis for channel opening by the key endogenous gating molecule
PI(4,5)P2.
Metabolic acidosis is a pathophysiological condition characterized by acid-base
imbalance in the body and it is common in people with kidney disease60. It has been
shown that TRPV5 dependent Ca2+ reabsorption decreases during chronic metabolic
acidosis and leads to kidney stone formation, suggesting that extracellular protons inhibit
the channel26,60. Moreover, it has been shown that not only extracellular pH, but also
intracellular protons regulate TRPV5 and have similar effects on single-channel
properties of the channel38,39. In this study, we established that lowering of pH leads to
the channel closing through the formation of the salt bridges around the proposed
intracellular pH sensor Lys607 in the channel36 and the hindrance of PI(4,5)P2 interaction
with TRPV5. The role of the salt bridge between Lys607 and Asp406 is supported both
by our finding that the Asp406Ala mutation eliminated inhibition of TRPV5 by pH 6.4 in
excised inside out patches, and by earlier findings that neutralization of the Lys607
residue reduced inhibition by low intracellular pH38. Additionally, Asp406 was previously
implicated in the binding site of the TRPV5 inhibitor ZINC17988990, highlighting its role
in channel inhibition43. Additionally, we showed that lowering the pH did not have an
effect on the position of the extracellular pH sensor Glu522 in the structures37,39,
nevertheless, it could be that cross talk between intracellular and extracellular TRPV5
sensors have additive effect on channel opening and closing36.
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We determined three structures of TRPV5 with added PI(4,5)P2 at pH 6.0. The lipid
density was only detectable in a subpopulation of the images where the channel was
preincubated at pH 8.0 with PI(4,5)P2 and pH was only lowered to 6.0 before freezing
the samples (TRPV5pH6+PIP2-state1). This suggests that we captured the channel in the
process of PI(4,5)P2 dissociating from the protein. When the channel protein was kept at
pH 6.0 before the addition of PI(4,5)P2 the lipid density was absent (TRPV5pH6-state3),
indicating that low pH prevented lipid binding to the protein. Intriguingly, our results are
in agreement with a recently proposed computational model for TRPV5 modulation by
PI(4,5)P261, which suggested that binding of PI(4,5)P2 to the channel depends on the
protonation state of the lipid. Establishing whether PI(4,5)P2 dissociation from the
channel is primarily cause by protonation of the lipid, conformational changes in the
protein, or their combination, will require more work. Overall, our data indicate that both
conformation changes around the S2-S3 and TRP helix that prevent channel from
opening together with the disruption of the PI(4,5)P2-protein interaction lead to channel
closing.
Our results on TRPV5 gating by PKA revealed that PKA transiently interacts with the
channel at the distal C-terminus and has minimal effect on overall conformational
changes. Yet, it supports a previously proposed model, which suggested that TRPV5
phosphorylation by PKA at the Thr709 abolishes CaM binding to TRPV524,30, causing
TRPV5 to remain in open /activated state but only in the presence of PI(4,5)P2. Our
structures of TRPV5T709D and TRPV5T709D+PIP2 showed states similar to TRPV5pH8 and
TRPV5pH8+PIP2, respectively. One noticeable difference was observed between
TRPV5pH8+PIP2 and TRPV5T709D+PIP2 structures, the TRPV5T709D+PIP2 pore did not capture a
fully open state. This is perhaps because we could only resolve a transitional state of the
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channel on the way to a fully open state or that the Thr709Asp phosphomimic mutation
affects the maximum pore opening. Our results again confirmed that PI(4,5)P2 is an
indispensable activator of TRPV516,17,25 and showed that PKA phosphorylation alone
does not open the channel24,30, but likely increases channel activity by preventing
inhibition by CaM.
TRPV5 and TRPV6 are closely related epithelial Ca2+ channels, the products of a
relatively recent gene duplication5,26. These two channels share 80% of sequence
homology (Fig. 2.S2) and they have very high functional similarity with each other, more
than with other members of the TRPV subfamily5,26. While there is no TRPV6 channel
structure in the presence of PI(4,5)P2 available, computational modeling and mutational
analysis indicate that PI(4,5)P2 binds to TRPV6 to the same conserved site as to
TRPV516 (Fig. 2.S2). The co-structure of TRPV6 with CaM62 is very similar to the two
available TRPV5 – CaM co-structures16,27, showing binding of CaM to equivalent
residues, and pore block by the same residue in CaM as in TRPV5. TRPV6 is also
inhibited by low pH63, and the equivalent residue that is phosphorylated by PKA in the
distal C-terminal CaM binding site in TRPV5, was shown to be phosphorylated by
Protein Kinase C (PKC) in human TRPV6, relieving CaM inhibition64. These structural
and functional similarities between TRPV5 and TRPV6 indicate that some, or all of, our
data may also be relevant for understanding the mechanism of gating of TRPV6.
Overall, these studies gave new structural and molecular insights into TRPV5 gating
by PI(4,5)P2, pH, CaM, and PKA. Based on our data, we propose that low pH acts as a
modulator of TRPV5 gating though formation of salt bridges around Lys607 and
alteration of PI(4,5)P2 binding to the channel, which subsequently leads to channel
closing (Fig. 2.6A). Additionally, we propose that phosphorylation of TRPV5 by PKA
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does not directly activate the channel, in agreement with the previously proposed
model24, and that phosphorylated TRPV5 still requires PI(4,5)P2 to open (Fig. 2.6B).
Nevertheless, PKA phosphorylation of TRPV5 at Thr709 residues prevents CaM binding
and channel inactivation, allowing more calcium to enter the cell. Our results provide
detailed insight into the mechanisms of TRPV5 modulation by endogenous modulators
at the molecular level, potentially aiding in the development of novel therapeutics to treat
hypercalciuria, nephrolithiasis, and osteoporosis.
Limitations of the study
In this study we determined the mechanism of TRPV5 modulation by lower pH. In
structural studies the pH of the whole sample is altered, thus specific effects of the
extracellular and intracellular pH cannot be evaluated, unlike in electrophysiology
experiment. Additionally, we were only able to investigate the effect of pH 6.0 on the
TRPV5 channel as lowering pH further, such as to pH 5.0, severely affected sample
quality. Another limitation of the study is that while we attempted to resolve the complex
between TRPV5T709D and CaM, we were unable to resolve any density attributed to CaM.
While this is compatible with the notion that phosphorylation reduced or eliminated
binding of CaM to the channel, we are unable to make firm conclusions on the apparent
affinity or the binding state of the phosphomimetic mutant of TRPV5 to CaM.
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Further information and requests for either resources or reagents should be directed to
and

will

be

fulfilled

by

the

lead

contact,

Vera

Moiseenkova-Bell

(vmb@pennmedicine.upenn.edu).
Materials availability
Requests for materials generated in this study should be directed to and will be fulfilled
by the lead contact Vera Moiseenkova-Bell (vmb@pennmedicine.upenn.edu).
Data and code availability
All data generated in these studies are available upon request from lead contact Vera
Moiseenkova-Bell (vmb@pennmedicine.upenn.edu). The cryo-EM density maps and
atomic coordinates have been deposited into the Electron Microscopy Data Bank
(EMDB) and Protein Data Bank (PDB), respectively. Accession codes are as follows:
TRPV5pH8 (EMD-25716, PDB 7T6J); TRPV5pH6 (EMD-25717, PDB 7T6K); TRPV5pH5
(EMD-25718, PDB 7T6L); TRPV5pH6+PIP2-state1 (EMD-25719, PDB 7T6M); TRPV5pH6-state2
(EMD-25720, PDB 7T6N); TRPV5pH6-state3 (EMD-25721, PDB 7T6O); TRPV5PKA (EMD25722); TRPV5T709D (EMD-25723, PDB 7T6P); TRPV5T709D+PIP2 (EMD-25724, PDB
7T6Q); and TRPV5T709D+CaM (EMD-25725, PDB 7T6R). Accession numbers are listed in
the key resources table. This paper does not report original code. Any additional
information required to reanalyze the data reported in this paper is available from the
lead contact upon request.

Experimental Model and Subject Details
For expression of TRPV5 channel in structural studies, BJ5457 Saccharomyces
cerevisiae (ATCC) was transfected with a YepM plasmid bearing rabbit TRPV5
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sequence with 1D4 epitope tag and maintained at 30 °C. For expression of rat
calmodulin, BL21(DE3) competent Escherichia coli were transformed with a pET28b
plasmid bearing the rat calmodulin sequence for inducible expression at 37 °C. For
expression of TRPV5 channel in electrophysiological studies, oocytes from Xenopus
Laevis were microinjected with cRNA encoding for rabbit TRPV5 and maintained at 18
°C. Additional details can be found in the method details.

Methods Details
Xenopus oocyte preparation and injection
Xenopus Laevis frogs (Xenopus Express) were anesthetized in Tricaine-S solution (0.5
g/L) and oocytes were extracted by the following sterile surgery protocol: Following a
small (~1cm) incision on the abdomen, the skin and the muscle were cut with scissors.
Oocyte sacks were collected gently with forceps and the incision was closed with suture
(Oasis PGA Absorbable Suture). The collected oocytes were digested in 0.2 mg/ml
collagenase (Sigma) in OR2 solution (82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, and 5 mM
HEPES, pH 7.4) rotating overnight at 18 °C. The defolliculated oocytes were washed
three times in OR2 and placed in OR2+ solution (OR2 solution supplemented with 1%
penicillin/streptomycin and 1.8 mM CaCl2) and kept at 18 °C. Healthy oocytes were
hand-selected under a microscope and were microinjected with cRNA using a nanoliter
injector system (World Precision Instruments). cRNA for this procedure was prepared by
mMessage mMachine T7 kit (Thermo Fisher) using wildtype or mutated rabbit TRPV5
DNA as template. Point mutations were generated by Quikchange XL mutagenesis kit
(Agilent Genomics).
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Electrophysiology
Two electrode voltage clamp experiments were performed as described earlier65. Briefly,
oocytes were bathed in a solution containing 97 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5
mM HEPES, pH 7.4. TRPV5 currents are blocked by Mg2+ and trace amounts of Ca2+
present in this solution. Monovalent currents were initiated by removing Mg2+ and traces
of Ca2+ by switching to a solution containing 96 mM LiCl, 1 mM EGTA, and 5 mM
HEPES, pH 7.4. LiCl is used as a charge carrier for monovalent currents, as it minimizes
endogenous currents in non-injected oocytes in divalent free solutions. Both
microelectrodes were placed in thin-wall inner filament-containing glass pipettes (World
Precision Instruments) filled with 3M KCl in 1% agarose. Currents were collected with a
GeneClamp 500B amplifier (Molecular Devices). A ramp protocol from –100 to +100 mV
(0.25 mV/ms) with a holding potential at 0 mV was applied. The pCLAMP software
(Molecular Devices) was used for data collection and analysis.
Excised inside-out patch clamp experiments were performed as described earlier65.
Patch clamp glass (World Precision Instruments PG10152-4) were pulled (Sutter
Instruments) to get pipettes with 0.6–1.3 MΩ resistance. Pipettes were filled with the
solution containing 96 mM LiCl, 1 mM EGTA, and 5 mM HEPES, pH 7.4. The oocytes
were placed in bath solution containing 96 mM KCl, 5 mM EGTA, and 10 mM HEPES,
pH 7.4 and devitellinized carefully by using sharp forceps. Following formation of the
gigaohm seal, a ramp protocol from – 100 to + 100 mV (0.25 mV/ms), immediately
preceded by a 100-ms step to − 100 mV was performed. diC8 PI(4,5)P2 (Cayman) was
dissolved in bath solution and applied to the intracellular side of the patch membrane
through a custom made perfusion system.
Cloning
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The YepM TRPV5 Thr709Asp mutant vector for protein expression in S. cerevisiae was
produced using a ligation-free cloning approach to introduce the point mutation with
primers. (See key resources table). YepM TRPV5 WT was used as a template and run
through 18 cycles of PCR with primers and Phusion master mix. Product was digested
using DpnI restriction enzyme to remove the template and the result was transformed
and purified in XL-Gold bacterial cells. Plasmid was sequenced to confirm incorporation
of the mutation.
TRPV5 protein preparation
TRPV5 was prepared as previously described16 and outlined 66. TRPV5 with a C-terminal
1D4 epitope tag was expressed in S. cerevisiae using a YepM vector67 transfected into
BJ5457 Saccharomyces cerevisiae (ATCC) using an alkali-cation yeast transformation
kit (MP Biomedicals) according to the manufacturer’s instruction. Cells were plated onto
SD-Leu agar plates and allowed to grow at 30° C for 2 days. Half of the colonies were
picked from one plate and inoculated into a single 75 mL starter culture containing SDLeu media and 10% v/v glycerol. The starter culture was allowed to grow at 30 °C until
the OD reached the top of the log phase (OD 1.0-1.4). About 2 mL of this culture was
inoculated into another 125 mL starter culture, and the cells were checked for TRPV5
expression by western blot with the 1D4 antibody68. Once expression was confirmed, the
cells were grown at 30 °C shaking at 200 RPM in 2.5 L of media per flask until the OD
reached the top of the log phase (OD 1.0-1.4). Cells were harvested by centrifugation at
3000 x g, resuspended in storage buffer (25 mM Tris-HCl, pH 8.0, 300 mM Sucrose, and
1 mM PMSF) on ice, then spun down at 3000 x g, discarding the supernatant. Cell
pellets were then stored at -80 °C. This expression culture was propagated with 15mL of
the previous growth at OD 1.0-1.4 for multiple days until the desired amount was grown.
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All subsequent steps were carried out at 4 °C unless noted otherwise. Cells from
approximately 60 L of growth were thawed and resuspended in 300 mL of
homogenization buffer (25 mM Tris-HCl, pH 8.0, 300 mM Sucrose, 5 mM EDTA, and
protease inhibitor cocktail). Resuspended cells were lysed using a M110Y microfluidizer
(Microfluidics) at 100 psi. The membranes were separated from cellular debris via
centrifugation at 3,000 x g for 10 minutes and subsequent centrifugation of the
supernatant at 14,000 x g for 35 minutes. Then using the previous spin’s supernatant,
the membranes were pelleted at 100,000 x g for 1 hour. Pelleted membranes were
harvested and resuspended on ice using a 15 mL tissue homogenizer (Kontes Duall with
PTFE pestle) in buffer containing 25 mM Tris-HCl, pH 8.0, 300 mM Sucrose, and 1 mM
PMSF then stored at -80 °C. TRPV5 was solubilized from the thawed membranes in
solubilization buffer (20 mM HEPES, pH 8.0, 150 mM NaCl, 2 mM TCEP, and 0.87 mM
LMNG). The insoluble fraction was separated by centrifugation at 100,000 x g for 1 hour.
The supernatant was incubated with 1D4-antibody coupled to CnBr-activated sepharose
beads for 3 hours. The beads were collected on a gravity flow column and washed with
wash buffer containing 20 mM HEPES, pH 8.0, 150 mM NaCl, 2 mM TCEP, and 0.064
mM DMNG. The beads were incubated with elution buffer (20 mM HEPES, pH 8.0, 150
mM NaCl, 2 mM TCEP, and 0.064 mM DMNG, 3 mg/mL 1D4 peptide) overnight. TRPV5
was eluted once every 5 minutes in ten 1 mL fractions. Peak fractions were pooled and
concentrated using a 100-kDa concentrator (Millipore). To reconstitute TRPV5 into
nanodiscs, an equimolar quantity of MSP2N2 protein69 was incubated with the
detergent-solubilized TRPV5 in the presence of soy polar lipids and DMNG detergent in
a reaction volume of 1mL. The ratio in the mixture of TRPV5:MSP2N2:Lipid:DMNG was
1:1:200:500. The reaction mixture was incubated on ice for 30 minutes, then about 30 µL
of Bio-Beads were added before rotating at 4 °C for 1 hour. The mixture was pipetted off
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of the used Bio-Beads into a new tube, then 30 µL of fresh Bio-Beads were added
before rotating at 4 °C overnight to complete the reaction. The reconstituted TRPV5 was
run on a Superose 6 increase 10/300 GL column (GE Healthcare) equilibrated with 20
mM HEPES, pH 8.0, 150 mM NaCl, 2 mM TCEP. Fractions containing nanodiscreconstituted TRPV5 were pooled and concentrated.
PKA phosphorylation assay and mass spectrometry
1 unit of PKAcat (New England Biolabs) was reacted with 1 ng of TRPV5 at 4 °C. Activity
was measured using the Biovision Universal Kinase Assay kit according to
manufacturer’s instruction. The fluorescence Ex/Em=535/587 nm was read on a plate
reader and signal was measured over time. To confirm the residue being
phosphorylated, 6.15 µM TRPV5 was incubated with 250 µM ATP, 12.5 mM MgCl2 and
1 unit of PKA for 16 hours. Mass spectrometry was performed on the TRPV5 band from
SDS-PAGE of this sample to confirm phosphorylation of residue Thr709.
CaM expression and purification
Rat CaM in a pET28b vector was expressed in BL21(DE3) Escherichia coli. Cells were
transformed then grown at 37 °C in Terrific Broth (TB) supplemented with 30 µg/mL
kanamycin. Expression was induced at OD 0.7 with 1 mM ITPG and grown for 4 hours.
Cells were harvested by centrifugation at 3000 x g and stored at -80 °C. Cells were
thawed and resuspended in buffer containing 50 mM Tris-HCl, pH 7.5, 2 mM EDTA, and
a complete EDTA-free protease inhibitor cocktail tablet (Roche). The cells were broken
in a M110Y microfluidizer at 80 psi and the lysate was spun at 20000 x g for 1 hour to
remove cellular debris. The supernatant was collected and supplemented with 5 mM
CaCl2. At room temperature, a HiTrap phenyl sepharose low sub fast flow column
(Cytiva) was equilibrated in 10 CV of equilibration buffer (50 mM Tris-HCl, pH 7.5, 5 mM
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CaCl2, 100 mM NaCl). Lysate was applied to the column and 10 CV of wash buffer (50
mM Tris-HCl, pH 7.5, 0.1 mM CaCl2, 100 mM NaCl) was used. A high salt wash (50 mM
Tris-HCl, pH 7.5, 0.1 mM CaCl2, 500 mM NaCl) was applied, then the protein was eluted
using elution buffer (50 mM Tris-HCl, pH 7.5, 1 mM EGTA) into 1 mL fractions. Fractions
containing protein were pooled and concentrated to 1 mL using a 10-kDa concentrator
(Millipore). Protein was further purified using size exclusion chromatography on a
Superdex S75 16/600 column (GE Healthcare) equilibrated with buffer containing 10 mM
Tris-HCl, pH 7.5, 10 mM CaCl2, 50 mM NaCl.
Cryo-EM sample preparation and data collection
All TRPV5 samples were processed similarly (Table 2.1). Samples TRPV5pH6, TRPV5pH5
with lower pH were spiked with sodium acetate pH 5.0 to adjust to desired pH 5 minutes
before freezing. Sample TRPV5PIP2+pH6 was incubated for 45 minutes with 400 µM diC8PI(4,5)P2 (Echelon Biosciences) then spiked with sodium acetate pH 5.0 to adjust to pH
6.0 before sample freezing. Sample TRPV5pH6-state3 was first spiked with sodium acetate
pH 5.0 to adjust to pH 6.0 then incubated with 400 µM diC8-PI(4,5)P2 for 45 minutes
before sample freezing. Sample TRPV5PKA was made by incubating TRPV5 (0.96 mg)
with PKAcat (2.6 U) in the presence of 420 µM ATP and 21 mM MgCl2 for 16 hours in a
total volume of 310 µL before sample freezing. Samples TRPV5pH8 and TRPV5T709D were
frozen directly after protein purification. TRPV5T709D+CaM was purified by first combining
purified TRPV5T709D in nanodiscs with purified rat CaM in a 1:20 molar ratio
supplemented with 10 mM CaCl2 for 1 hour. This mixture was then purified on a
Superose 6 increase 10/300 GL column (GE Healthcare) equilibrated with 20 mM
HEPES, pH 8.0, 150 mM NaCl, 2 mM TCEP. TRPV5T709D+CaM was concentrated and then
frozen. Using a Vitrobot Mark IV (Thermo Scientific), 3 µL of the samples were applied
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onto glow-discharged 1.2/1.3 Quantifoil Holey Carbon Grids (Quantifoil Micro Tools).
The sample was blotted in a chamber at 4 °C and 100% humidity for 6-9 seconds with 0
blot force before being frozen in liquid ethane. TRPV5PKA sample was imaged on a Titan
Krios 300 kV electron microscope with a Gatan K2 direct electron detector. 60 frame
movies were collected with a nominal dose of 72 e-/Å2. Super-resolution images for the
TRPV5PKA dataset were collected at a magnification of 130,000 and had a pixel size of
0.535 Å/pixel. All other samples were imaged on a Titan Krios G3i 300 kV electron
microscope with a Gatan K3 direct electron detector. 40 frame movies were collected
with a nominal dose of 42 e-/Å2. Super-resolution images for TRPV5pH8, TRPV5pH5,
TRPV5pH6-state3, and TRPV5T709D+CaM datasets were collected at a magnification of
105,000 and had a pixel size of 0.415 Å/pixel. Super-resolution images for TRPV5pH6,
TRPV5PIP2+pH6, TRPV5T709D, and TRPV5T709D+PIP2 datasets were collected at a
magnification of 81,000 and had a pixel size of 0.53 Å/pixel.
Data processing
All datasets were processed similarly using cryoSPARC v3.2.045,70,71. For the TRPV5pH8
dataset, 2,350 movies were collected. Movies were patch motion corrected with an
alignment resolution of 3 Å and Fourier cropped to half the resolution. The micrographs
were then run through patch CTF estimation. The micrographs were then autopicked
using 2D templates generated from a subset of 100 micrographs. 242,844 particles were
extracted and binned by a factor of 2 with a box size of 144 pixels and sorted with 2D
classification. 111,116 particles remained after 1 round of 2D classification. Ab-initio
reconstruction with 1 class was used to generate the initial structure. These particles
were then subjected to heterogeneous refinement with 5 classes. One class with 54,415
particles was taken and particles were extracted in an unbinned box size of 288 pixels.
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Particles were subjected to Non-uniform (NU) refinement in C1 symmetry (3.5 Å) and
subsequently C4 symmetry (3.2 Å). Global and local CTF refinement were performed
and the final NU refinement in C4 symmetry gave a 3.2 Å structure.
For the TRPV5pH6 dataset, 4,679 movies were collected. Movies were patch motion
corrected with an alignment resolution of 3 Å and Fourier cropped to half the resolution.
The micrographs were then run through patch CTF estimation. 740 micrographs with
estimated max resolutions below 4 Å were excluded from further processing. The
remaining 3939 micrographs were then autopicked using 2D templates generated from a
subset of 100 micrographs. 578,132 particles were extracted and binned by a factor of 2
with a box size of 128 pixels and sorted with 2D classification. 158,001 particles
remained after 1 round of 2D classification. Ab-initio reconstruction with 3 classes was
used to generate the initial structure. One class was taken, and 104,184 particles were
extracted in a unbinned box size of 256 pixels. These particles were then subjected to
heterogeneous refinement with 3 classes. One class with 57,036 particles was taken to
Non-uniform (NU) refinement in C1 symmetry (3.4 Å) and subsequently C4 symmetry
(3.2 Å). Global and local CTF refinement were performed and NU refinement in C4
symmetry gave a 3.0 Å structure. Some heterogeneity remained, so one more round of
heterogeneous refinement in C4 symmetry yielded a class with 27,988 particles. The
final model was solved by NU-refinement with defocus and global CTF refinements to
3.0 Å resolution in C4 symmetry.
For the TRPV5pH5 dataset, 1,663 movies were collected. Movies were patch motion
corrected with an alignment resolution of 3 Å and Fourier cropped to half the resolution.
The micrographs were then run through patch CTF estimation. 213 micrographs with
estimated max resolutions below 5 Å were excluded from further processing. The
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remaining 1,450 micrographs were then autopicked using 2D templates generated from
a subset of 200 micrographs. 221,439 particles were extracted binned by a factor of 4
with a box size of 96 pixels and sorted with 2D classification. 24,329 particles remained
after 2 rounds of 2D classification. Particles were reextracted in an unbinned box size of
384 pixels. Ab-initio reconstruction of these particles into 3 classes gave one class with
11,398 particles that was subjected to NU refinement in C1 symmetry (4.9 Å) followed by
C4 symmetry (3.7 Å). No heterogeneity was seen and the final model with a resolution of
3.7Å was used.
For the TRPV5PIP2+pH6 dataset, 7,006 movies were collected. Movies were patch motion
corrected with an alignment resolution of 3Å and Fourier cropped to half the resolution.
The micrographs were then run through patch CTF estimation. 507 micrographs with
estimated max resolutions below 5 Å were excluded from further processing. The
remaining 6,499 micrographs were then autopicked using 2D templates generated from
a subset of 200 micrographs. 1,536,734 particles were extracted binned by a factor of 4
with a box size of 64 pixels and sorted with 2D classification. 599,459 particles remained
after 1 round of 2D classification. These particles were extracted in an unbinned box size
of 256 pixels. Ab-initio reconstruction with 1 class was used to generate the initial
structure that was subjected to Non-uniform (NU) refinement in C1 symmetry (2.9 Å)
followed by C4 symmetry (2.8 Å). Using symmetry expansion and 3D variability
clustering analysis, the data was divided into 5 clusters. Two clusters represented the
open and closed state of the channel. State1 had 102,424 particles and state2 had
114,598 particles after reverting to their original, non-symmetry expanded state. The
other three clusters were intermediate states on the transition between state1 and
state2. NU refinement in C4 symmetry yielded structures of TRPV5pH6+PIP2-state1 to 2.8 Å
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and TRPV5pH6-state2 to 3.0 Å. Heterogeneous refinement with 3 classes yielded 1 class for
each state that went to high resolution. The best class for TRPV5pH6+PIP2-state1 contained
63,746 particles and the best class for TRPV5pH6-state2 contained 67,926 particles. For the
final models, NU refinement was performed in C4 symmetry on TRPV5pH6+PIP2-state1 and
TRPV5pH6-state2, yielding maps with 2.8 Å and 2.9 Å resolution, respectively.
For the TRPV5pH6-state3 dataset, 11,244 movies were collected. Movies were patch motion
corrected with an alignment resolution of 3 Å and Fourier cropped to half the resolution.
The micrographs were then run through patch CTF estimation. 605 micrographs with
estimated max resolutions below 5 Å were excluded from further processing. The
remaining 10,639 micrographs were then autopicked using 2D templates generated from
a subset of 200 micrographs. 1,772,051 particles were extracted binned by a factor of 4
with a box size of 96 pixels and sorted with 2D classification. 373,133 particles remained
after 2 rounds of 2D classification. These particles were extracted in an unbinned box
size of 384 pixels. Ab-initio reconstruction with 1 class was used to generate the initial
structure that was subjected to Non-uniform (NU) refinement in C1 symmetry (2.9 Å)
followed by C4 symmetry (2.6 Å). The particles were then subjected to heterogeneous
refinement with 4 classes with C4 symmetry. Only one class went to high resolution with
241,089 particles. This subset of particles was subjected to NU refinement in C4
symmetry (2.5 Å). Using symmetry expansion and 3D variability analysis, it was found
that not much movement existed in the channel except for some heterogeneity at the
lower gate Trp583 residue. One more round of heterogeneous refinement with 4 classes
yielded 3 classes with a stable density for residue Trp583 totaling 172,497 particles and
1 class with the heterogeneous density totaling 68,592 particles. The remainder of the
density between these two types of classes was identical. For the final model, NU
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refinement was performed in C4 symmetry on the classes with stable density, yielding a
map with 2.6 Å resolution.
For TRPV5PKA, two datasets were used from the same grids with 7,393 and 8,732
movies for dataset 1 and 2 respectively. Movies were patch motion corrected with an
alignment resolution of 3 Å and Fourier cropped to half the resolution. The micrographs
were then run through patch CTF estimation. 1,053 micrographs from dataset 1 and
2,171 micrographs from dataset 2 with estimated max resolutions below 5 Å were
excluded from further processing. The remaining 6,240 and 6,561 micrographs were
then separately autopicked using 2D templates generated from subsets of 100
micrographs. 554,184 and 733,430 particles were extracted binned by a factor of 2 with
a box size of 128 pixels and sorted with 2D classification. 123,348 and 172,798 particles
remained after 1 round of 2D classification in each respective dataset. Particles were
then combined and ab-initio reconstruction into 6 classes gave 1 class with 148,299
particles. Homogeneous refinement in C1 symmetry yielded a 4.5 Å structure. Extraction
of these particles in an unbinned box size of 256 pixels allowed homogeneous
refinement to reach 3.7 Å. However, it was apparent that this sample had some dimers
of TRPV5 tetramers. To sort these particles, they were extracted in a larger box size of
416 pixels and 2D classified to efficiently remove these dimers. Homogeneous
refinement reached to 3.7 Å. Particles were then taken to heterogenous refinement with
3 classes in C1 symmetry, and the best class with 69,059 particles was taken and NU
refinement was performed resulting in a 3.3 Å structure in C4 symmetry. An additional
round of heterogenous refinement into 3 classes in C4 symmetry gave 1 class with good
density for the channel containing 43,926 particles. NU refinement in C4 symmetry gave
a 3.2 Å structure. Global and local CTF refinement followed by one more NU refinement
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in C4 symmetry gave a 3.1 Å structure. This structure, even in C4 symmetry had extra
density inside the ARD skirt of the channel. To investigate, symmetry expansion and 3D
variability analysis of 5 component modes was performed. Three of the components
showed variability in the ARD skirt, so particles along the axis of this variability when the
extra density appears were taken by specifying the coordinate along each mode. From
this, 6,016 non-symmetry expanded particles made up the small subset of particles with
this density. A final local refinement centered on this density was performed in C1
symmetry, yielding a 4.2 Å structure.
For the TRPV5T709D dataset, 10,011 movies were collected. Movies were patch motion
corrected with an alignment resolution of 5 Å and Fourier cropped to half the resolution.
The micrographs were then run through patch CTF estimation. 1,211 micrographs with
estimated max resolutions below 5 Å were excluded from further processing. The
remaining 8,800 micrographs were then autopicked using 2D templates generated from
a subset of 100 micrographs. 2,747,656 particles were extracted binned by a factor of 2
and sorted with 2D classification. 938,370 particles remained after 1 round of 2D
classification. Ab-initio reconstruction with 5 classes was performed and resulted in 1
good class to be used as the initial volume for NU refinement in C1 symmetry which
gave a 4.3Å structure. Extraction of the unbinned particles with a box size of 256 and NU
refinement yielded a structure with a resolution of 3.1 Å in C1 symmetry, and 3.0 Å in C4
symmetry. Heterogeneous refinement into 5 classes gave 1 class that went to high
resolution containing 419,343 particles. Final NU refinement in C4 symmetry yielded a
map with 2.8 Å resolution.
For the TRPV5T709D+PIP2 dataset, 10,021 movies were collected. Movies were patch
motion corrected with an alignment resolution of 5 Å and Fourier cropped to half the
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resolution. The micrographs were then run through patch CTF estimation. 1,960
micrographs with estimated max resolutions below 5 Å were excluded from further
processing. The remaining 8,061 micrographs were then autopicked using 2D templates
generated from a subset of 100 micrographs. 1,306,911 particles were extracted binned
by a factor of 2 with a box size of 128 pixels and sorted with 2D classification. 342,338
particles remained after 1 round of 2D classification. Ab-initio reconstruction with 5
classes was performed and resulted in 1 good class to be used as the initial volume for
heterogeneous refinement in C1 symmetry which gave one good class containing
157,152 particles. Extraction of the unbinned particles with a box size of 256 and NU
refinement yielded a structure with a resolution of 3.4 Å in C1 symmetry, and 3.2 Å in C4
symmetry. Global and local CTF refinement improved the resolution to 3.1 Å with NU
refinement in C4 symmetry. Symmetry expansion and 3D variability analysis with 5
clusters allowed for sorting of the open state of the channel with bound PI(4,5)P2
containing 30,765 particles. Final NU refinement in C4 symmetry yielded a map with 3.4
Å resolution.
For the TRPV5T709D+CaM dataset, 9,830 movies were collected. Movies were patch motion
corrected with an alignment resolution of 3 Å and no Fourier cropping. The micrographs
were then run through patch CTF estimation. 1,857 micrographs with estimated max
resolutions below 5 Å were excluded from further processing. The remaining 7,972
micrographs were then autopicked using 2D templates generated from a subset of 200
micrographs. 961,168 particles were extracted binned by a factor of 8 with a box size of
72 pixels and sorted with 2D classification. 198,687 particles remained after 1 round of
2D classification. Ab-initio reconstruction with 1 class was performed on these binned
particles. Extraction was then performed binned by a factor of 2 with a box size of 288
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pixels. NU refinement was performed in C1 symmetry to a resolution of 3.3 Å.
Heterogeneous refinement into 6 classes using initial models of the previous model and
imported TRPV5 CaM complex from EMD-7967 gave 1 class that was capable of
reaching high resolution. There was no indication of any additional density belonging to
CaM in any of the models. NU refinement in C1 and C4 symmetry yielded 3.2 Å and 3.0
Å maps that were identical. The C4 map was taken as the final model.
Model building
The previously determined full-length rabbit TRPV5 structure (PDB: 6DMR) was used as
the starting model and docked into each structure and manually fit and adjusted in
COOT72 then refined in PHENIX using phenix.real_space_refine with C4 symmetry73.
Residues 1-28, 226-229, and 640-730 were excluded from the model because the
density was not resolved. The ligand restraint file for PI(4,5)P2 was generated by the
eLBOW tool within the PHENIX software package74. Models were then aligned and
visualized using Pymol and Chimera and ChimeraX75-78. Pore radii were measured using
HOLE79. Model to map fit was assessed using EMRinger80.

Quantification and Statistical Analysis
Cryo-EM data were processed using cryoSPARC v3.2.045,70,71. Cryo-EM structural
statistics were analyzed by Phenix73, Molprobity81, EMRinger80 and UCSF Chimera77.
Standard deviation is used to create error bars in Figures 2.1A, 2.4E, and 2.5J. Twosample t-test was performed in Figure 2.4E. Statistical details are explained in the figure
captions.
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Figure 2.1. TRPV5 structures and function in high and low pH. (A) TEVC data
showing TRPV5 channel activity in Xenopus oocytes under various pH states.
Measurement of monovalent currents through TRPV5 were performed as described in
the methods section. Currents were normalized to pH 7.4 values for each oocyte and
plotted as mean ± SD and scatter plots. (B) Pore diagram plotting pore radius of
TRPV5pH8 (blue), TRPV5pH6 (teal), and TRPV5pH5 (wheat) as a function of distance along
the ion conducting pore. (C) Pore profile of TRPV5pH8 (blue), TRPV5pH6 (teal), and
TRPV5pH5 (wheat) highlighting constriction residues D542, I575, and W583. (D)
Residues around the intracellular pH sensor K607 are highlighted with distances labeled
between residues involved in salt bridge formation. (E) Extracellular pH sensor E522. (F)
Comparison between TRPV5pH6 (teal) and TRPV5pH5 (wheat) in reference to TRPV5pH8
(blue) showing the positions of the ARD. (G) Comparison between TRPV5pH6 (teal) and
TRPV5pH5 (wheat) in reference to TRPV5pH8 (blue) showing the rotation of the ARD.
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Figure 2.2. Interplay between pH and PI(4,5)P2 on TRPV5 structure. Pore profiles of
(A) TRPV5pH8+PIP2 (pale green), (B) TRPV5pH6+PIP2-state1 (dark green), (C) TRPV5pH6-state2
(dark red), and (D) TRPV5pH6-state3 (orange). (E) The pore diagram plotted along the ion
conducting pore. (F-I) Residues around the intracellular pH sensor K607 are highlighted
with distances labeled between residues involved in salt bridge formation. (J)
Extracellular pH sensor E522.
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Figure 2.3. PI(4,5)P2 binding site of TRPV5 and effect on channel gating. (A-D) View
of the pore profile of TRPV5pH8+PIP2 (pale green), TRPV5pH6+PIP2-state1 (dark green),
TRPV5pH6-state3 (orange) and TRPV5T709D+PIP2 (purple) highlighting constriction residues
D542, I575, and W583 along with (E) the pore diagram plotting pore radius as a function
of distance along the ion conducting pore. (F-I) PI(4,5)P2 binding sites of each model
with overlayed density contoured at σ = 3.5. (J-M) Close up of PI(4,5)P2 binding sites
with the positions of R302, R305, K484, and R584. (N-Q) Calculated electrostatic
potential of PI(4,5)P2 binding sites.
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Figure 2.4. Conformational changes of TRPV5 with pH and PI(4,5)P2. (A) Overlay of
monomers in two views and movements of TRPV5pH6+PIP2-state1 (dark green) and
TRPV5pH6-state2 (dark red) in reference to TRPV5pH8+PIP2 (pale green). (B) Comparison of
TRPV5pH6+PIP2-state1 (dark green) and TRPV5pH6-state2 (dark red) in reference to
TRPV5pH8+PIP2 (pale green) showing the positions and rotation of the ARD. (C) Overlay of
monomers in two views and movements of TRPV5pH6-state3 (orange) and TRPV5pH6 (teal)
in reference to TRPV5pH8+PIP2 (pale green). (D) Comparison of TRPV5pH6-state3 (orange)
and TRPV5pH6 (teal) in reference to TRPV5pH8+PIP2 (pale green) showing the positions
and rotations of the ARD. (E) Data Summary of TRPV5 excised inside out patch clamp
experiments (see Methods). Current values (-100 mV) at pH 6.4 are normalized to pH
7.4 for WT TRPV5 and for the D406A mutant. First column visually shows the reference
point (pH 7.4), and two sample t-test was used to compare WT and D406A data points.
Data
was
plotted
as
mean
±
SD. (F) Representative
traces
show
monovalent inward currents at -100, 0 and 100 mV. Currents were evoked after rundown
by application of 25 μM diC8 PI(4,5)P2, the pH of the solution was alternated between pH
7.4 and pH 6.4.
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Figure 2.5. TRPV5 in a phosphorylated state interacts with PI(4,5)P2. Pore profile of
(A) TRPV5pH8 (blue), (B) TRPV5T709D (pink), (C) TRPV5T709D+PIP2 (purple), and (D)
TRPV5pH8+PIP2 (pale green) highlighting constriction residues D542, I575, and W583
along with (E) the pore diagram plotting pore radius as a function of distance along the
ion conducting pore. (F) Overlay of monomers in two views and movement of
TRPV5T709D (pink) in reference to TRPV5pH8 (blue). (G) Comparison of TRPV5T709D (pink)
in reference to TRPV5pH8 (blue) showing the position, but lack of rotation of the ARD (H)
Overlay of monomers in two views and movements of TRPV5T709D (pink) and
TRPV5T709D+PIP2 (purple) in reference to TRPV5pH8+PIP2 (pale green). (I) Comparison of
TRPV5T709D (pink) and TRPV5T709D+PIP2 (purple) in reference to TRPV5pH8+PIP2 (pale
green) showing the positions and rotations of the ARD. (J) Excised inside out patch
clamp experiments from Xenopus oocytes expressing either WT TRPV5 or T709D
mutant TRPV5 under different concentrations of PI(4,5)P2. Currents at -100 mV were
normalized to 50 µM PI(4,5)P2 for each patch and plotted as mean ± SD and scatter
plots on the bar graph. (K) Representative traces for excised patch experiments.
Measurement of monovalent TRPV5 currents were performed as described in the
methods section. Top traces show currents at 100 mV, bottom traces at -100 mV,
dashed lines show zero current. The establishment of the inside out configuration (i/o) is
indicated by the arrows. Different concentrations of diC8 PI(4,5)P2 were applied after
current rundown, as indicated by the thick horizontal lines.
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Figure 2.6. Proposed mechanisms of TRPV5 modulation by pH and PKA. (A) The
mechanism of TRPV5 closing with low pH. (B) The mechanism of inactivation by CaM
and activation by PKA.

53

Table 2.1: Refinement statistics for TRPV5 structures
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Table 2.2: Key resources table
REAGENT or RESOURCE
Antibodies

SOURCE

IDENTIFIER

1D4 primary antibody

(Hodges et al., 1988)

N/A

XL10-Gold

Agilent

Cat # 200315

BL21(DE3)

Invitrogen

Cat# 44-0048

Bacterial and virus strains

Chemicals, peptides, and recombinant proteins
Collagenase

Sigma

Cat# C9891-1G

DpnI restriction enzyme

New England Biolabs

Cat# R0176S

SD-Leu Media

MP Biomedicals

Cat# 4811075

Glycerol

Fisher BioReagents

Cat# BP229-4

Protease inhibitor cocktail

Sigma

Cat# P8215

CnBr-activated sepharose beads

Cytiva

Cat# 17043001

1D4 peptide

Genscript

N/A

Lauryl Maltose Neopentyl Glycol (LMNG)

Anatrace

Cat# NG310

Decyl Maltose Neopentyl Glycol (DMNG)

Anatrace

Cat# NG322

TCEP

Pierce

Cat# PG82090

Soy polar lipids

Avanti

Cat # 541602C

MSP2N2

(Grinkova et al., 2010)

Addgene #29520

Bio-Beads SM-2 Absorbent media

BioRad

Cat# 152-8920

diC8-PI(4,5)P2

Cayman

Cat # 64910

diC8-PI(4,5)P2

Echelon Biosciences

Cat# P-4508

cAMP-dependent Protein Kinase (PKA),
catalytic subunit

New England Biolabs

Cat# P6000S

mMessage mMachine T7 kit

Thermo Fisher

Cat# AM1344

Quikchange XL mutagenesis kit

Agilent Genomics

Cat# 200516

Critical commercial assays
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Phusion Master Mix

Thermo Scientific

Cat# F-531S

Alkali-Cation Yeast Transformation Kit

MP Biomedicals

Cat# 2200200

Universal Kinase Assay kit

Biovision

Cat# K212-100

This paper

EMD-25716

Deposited data
TRPV5pH8

PDB: 7T6J
TRPV5pH6

This paper

EMD-25717
PDB: 7T6K

TRPV5pH5

This paper

EMD-25718
PDB: 7T6L

TRPV5pH6+PIP2-state1

This paper

EMD-25719
PDB: 7T6M

TRPV5pH6-state2

This paper

EMD-25720
PDB: 7T6N

TRPV5pH6-state3

This paper

EMD-25721
PDB: 7T6O

TRPV5PKA

This paper

EMD-25722

TRPV5T709D

This paper

EMD-25723
PDB: 7T6P

TRPV5T709D+PIP2

This paper

EMD-25724
PDB: 7T6Q

TRPV5T709D+CaM

This paper

EMD-25725
PDB: 7T6R

TRPV5pH8+PIP2

(Hughes et al., 2018b)

EMD-7966
PDB: 6DMU

Experimental models: Organisms/strains
Saccharomyces cerevisiae BJ5457

ATCC

208282

Xenopus laevis

Xenopus Express

Cat# LB-XL-FM
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Oligonucleotides
TRPV5 T709D forward primer

This paper

N/A

This paper

N/A

YepM rabbit TRPV5 plasmid

(Hughes et al., 2018a;
Moiseenkova-Bell et
al., 2008)

N/A

YepM rabbit TRPV5 T709D plasmid

This paper

N/A

pGEMSH rabbit TRPV5 plasmid

(Hughes et al., 2018a)

N/A

pET28b rat calmodulin plasmid

(Zhang et al., 2014)

N/A

pCLAMP

Molecular Devices

https://www.moleculard
evices.com/products/ax
on-patch-clampsystem/acquisition-andanalysissoftware/pclampsoftware-suite

cryoSPARC v3.2.0

(Punjani and Fleet,
2021; Punjani et al.,
2017; Punjani et al.,
2020)

https://cryosparc.com/

Coot

(Emsley and Cowtan,
2004)

https://www2.mrclmb.cam.ac.uk/personal
/pemsley/coot/

Phenix 1.18.2-3874

(Adams et al., 2002)

https://phenixonline.org/documentati
on/index.html

eLBOW

(Moriarty et al., 2009)

https://phenixonline.org/documentati
on/reference/elbow_gui
.html

Molprobity

(Chen et al., 2010)

http://molprobity.bioche
m.duke.edu/

CCTTCGTCGAAACGACTTGGGACACT
TGAATCTTGG
TRPV5 T709D reverse primer
CCAAGATTCAAGTGTCCCAATCTGTTT
CGACGAAGG
Recombinant DNA

Software and algorithms
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EMRinger

(Barad et al., 2015)

https://github.com/frase
r-lab/EMRinger

HOLE

(Smart et al., 1996)

http://www.holeprogram
.org/

PyMOL

(Schrodinger, 2015)

https://pymol.org/2/

Chimera

(Pettersen, 2004)

https://www.cgl.ucsf.ed
u/chimera/

ChimeraX

(Goddard et al., 2018;
Pettersen et al., 2021)

https://www.cgl.ucsf.ed
u/chimerax/

Med Vet International

Cat# MVJ397

Other
Oasis PGA Absorbable Suture
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Figure 2.S1. TRPV5pH8, TRPV5pH6, and TRPV5pH5 cryoEM data. Related to Figure
2.1. (A) Representative micrograph and 2D classes. (B) Local resolution estimate
calculated in cryoSPARC shown as a side view with estimated resolutions. (C) Angular
distribution of final cryoEM reconstruction where taller red cylinders indicate more
particles aligned at an angle, and shorter blue cylinders indicate less particles. (D) Map
FSC curves. (E) TRPV5pH8 representative sidechain densities contoured at σ = 4. (F)
TRPV5pH6 representative sidechain densities contoured at σ = 4. (G) TRPV5pH5
representative sidechain densities contoured at σ = 4.
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Figure 2.S2. TRPV5 domain architecture, structure and sequence. Related to
Figure 2.1. Representative (A) cryoEM density map of TRPV5 with views of side (left),
top (center), and bottom (right) with individual monomers colored as red, purple, green
and teal. Associated lipids are colored in khaki. (B) cryoEM density map of individual
monomer of TRPV5 and (C) model colored by domain: ARD (pink), N-linker (yellow), S1S4 (light green), S5-PH-S6 (blue), TRP domain (orange) and CTD (red). (D) Cartoon
representation of TRPV5 domains. (E) Sequence alignment of TRPV5 and TRPV6.
Rabbit TRPV5, rat TRPV6, human TRPV5, and human TRPV6 sequence alignment
shows sequence conservation of important residues for intracellular (red) and
extracellular (purple) pH sensing, PI(4,5)P2 binding (blue) and PKA phosphorylation
(orange). TRPV5 and TRPV6 domains are labeled above the sequence.
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Figure 2.S3. Pore constriction residue cryoEM density. Related to Figures 2.1, 2.2,
and 2.5. (A) Densities for Asp542, Ile575, and Trp583 in TRPV5pH8 (blue), TRPV5pH6,
(teal), TRPV5pH5 (wheat), TRPV5pH6+PIP2+PIP2-state1 (dark green), TRPV5pH6-state2 (dark red),
TRPV5pH6-state3 (orange) and TRPV5pH8+PIP2 (pale green) models listed with map
resolution. Density is contoured at σ = 4. Distances between constriction residues are
shown with a dotted line. (B) Densities for Asp542, Ile575, and Trp583 in
TRPV5T709D+PIP2 (purple), TRPV5T709D (pink), and TRPV5T709D+CaM (brown) models listed
with map resolution. Density is contoured at σ = 4. Distances between constriction
residues are shown with a dotted line.
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Figure 2.S4. Sidechain density of salt bridge residues. Related to Figures 2.1 and
2.2. (A) TRPV5pH8 (blue), TRPV5pH6, (teal), and TRPV5pH5 (wheat) models with
overlayed cryoEM density for residues Glu294, Asp406, Arg409, Arg606, and Lys607.
Density is contoured at σ = 4. Distances between residues are shown with a dotted line.
(B) Overlayed cryoEM density maps comparing TRPV5pH8 (blue) to TRPV5pH6 (teal) and
TRPV5pH5 (wheat). Density is contoured to threshold values of 0.164 for TRPV5pH8
(blue), 0.27 for TRPV5pH6 (teal), and 0.121 for TRPV5pH5 (wheat). (C) TRPV5pH8+PIP2
(pale green), TRPV5pH6+PIP2-state1 (dark green), TRPV5pH6-state2 (dark red), and TRPV5pH6state3 (orange) models with overlayed EM density for residues Glu294, Asp406, Arg409,
Arg606, and Lys607. Density is contoured at σ = 4. Distances between residues are
shown with a dotted line. (D) Overlayed EM density maps comparing TRPV5pH8+PIP2 (pale
green) to TRPV5pH6+PIP2-state1 (dark green), TRPV5pH6-state2 (dark red), and TRPV5pH6-state3
(orange). Density is contoured to threshold values of 0.0561 for TRPV5pH8+PIP2 (pale
green), 0.329 for TRPV5pH6+PIP2-state1 (dark green), 0.304 for TRPV5pH6-state2 (dark red),
and 0.243 for TRPV5pH6-state3 (orange).
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Figure 2.S5. TRPV5pH6+PIP2-state1, TRPV5pH6-state2, and TRPV5pH6-state3 cryoEM data.
Related to Figure 2.2. (A) Representative micrograph and 2D classes. (B) Local
resolution estimate calculated in cryoSPARC shown as a side view with estimated
resolutions. (C) Angular distribution of final cryoEM reconstruction where taller red
cylinders indicate more particles aligned at an angle, and shorter blue cylinders indicate
less particles. (D) Map FSC curves. (E) TRPV5pH6+PIP2-state1 representative sidechain
densities contoured at σ = 4. (F) TRPV5pH6-state2 representative sidechain densities
contoured at σ = 4. (G) TRPV5pH6-state3 representative sidechain densities contoured at σ
= 4.
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Figure 2.S6. TRPV5 interactions with PKA and CaM. Related to Figure 2.5. (A)
Fluorescent readout (ΔRFU Ex/Em =535/587 nm) over time (minutes) of the formation of
ADP upon incubation of TRPV5 with PKAcat. Data were plotted as mean ± SE at each
timepoint. (B) Representative micrograph and 2D classes of TRPV5PKA cryoEM data. (C)
Map FSC curves. (D) Angular distribution of final cryoEM reconstruction where taller red
cylinders indicate more particles aligned at an angle, and shorter blue cylinders indicate
less particles. (E) Local resolution estimate calculated in cryoSPARC shown on side
(left), top (center) and bottom (right) views with estimated resolutions 4.0 Å (blue), 6.0 Å
(white), and 8.0 Å (red). (F) cryoEM density map of TRPV5PKA shown in yellow. (G)
TRPV5PKA lowpass filtered to 10 Å resolution with TRPV5 density shown in yellow and
density attributed to PKA shown in green. Bottom view (above) and sliced-side (below)
views are shown. (H) TRPV5CaM lowpass filtered to 10 Å resolution with TRPV5 density
shown in blue and density of CaM shown in magenta. Bottom view (above) and slicedside (below) views are shown. (I) Overlay of monomers in two views and movements of
TRPV5T709D (pink) and TRPV5T709D+CaM (brown) in reference to TRPV5pH8 (blue). (J)
Comparison of TRPV5T709D (pink) and TRPV5T709D+CaM (brown) in reference to TRPV5pH8
(blue) showing slight shifts in the positions and no rotation of the ARD.
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Figure 2.S7. TRPV5T709D, TRPV5T709D+PIP2, and TRPV5T709D+CaM cryoEM data. Related
to Figure 2.5. (A) Representative micrograph and 2D classes. (B) Local resolution
estimate calculated in cryoSPARC shown as a side view with estimated resolutions. (C)
Angular distribution of final cryoEM reconstruction where taller red cylinders indicate
more particles aligned at an angle, and shorter blue cylinders indicate less particles. (D)
Map FSC curves. (E) TRPV5T709D representative sidechain densities contoured at σ = 4.
(F) TRPV5T709D+PIP2 representative sidechain densities contoured at σ = 4. (G)
TRPV5T709D+CaM representative sidechain densities contoured at σ = 4.
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CHAPTER 3: SUMMARY AND FUTURE DIRECTIONS

3.1 Summary
Presented here is the summation of my work on TRPV5 that was the focus of my
thesis work. In Chapter 2, I presented the results of my studies on the structural basis of
TRPV5 regulation by physiological and pathophysiological modulators. Cryo-EM was a
powerful technique that allowed us to solve structures under conditions of interest.
These findings were the first to study the structure of TRPV5 under effects of low pH and
phosphorylation by PKA. Interestingly, we were able to determine conformational
changes of the channel under low pH conditions but did not see many structural
changes in response to phosphorylation. I was able to solve a total of ten TRPV5
structures that together gave a comprehensive picture into the mechanisms of these
modes of modulation.
While the overall domain architecture and arrangement of these new TRPV5
structures determined were identical to previous structures, structural shifts were
determined that gave insights into the gating mechanisms of TRPV5. For TRPV5
modulation by pH, several significant differences were seen. The first was the change in
the ion-conducting pore, where it became more constricted under low pH conditions. A
new conformation was seen at the bottom of the pore at residue W583 which adopted a
rotated conformation that further constricted the pore and was not seen in previously
solved structures. Additionally, salt bridge interactions were formed in the low pH
conditions around the intracellular pH sensor, K607, that we propose stabilize the closed
state of the channel. One of the key residues forming a salt bridge with K607 was D406
from the S2-S3 linker region. This important interaction was confirmed using
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electrophysiology on the D406A TRPV5 mutant which instead displayed increased
activity under low pH conditions. Finally, low pH also inhibited TRPV5 through its effects
on PI(4,5)P2 binding, causing dissociation of activating PI(4,5)P2 from the channel.
For TRPV5 modulation by PKA, we found that the catalytic subunit of PKA could
transiently associate with TRPV5 as shown by the extra density in our structure solved in
the presence of PKAcat. This density overlaps with the site for CaM binding to TRPV5.
PKA phosphorylation of TRPV5 was then studied using a phosphomimic mutation on the
site of phosphorylation at T709. The structures of this mutant did not show many
structural changes to explain direct activation by phosphorylation. Therefore, we
concluded that PKA phosphorylation at T709 disrupts the CaM binding site of TRPV5,
blocking inactivation. However, PI(4,5)P2 binding was still required for channel activation.

3.2 Impact
These studies provided the constantly developing TRP channel field with useful
new information. Our studies have built upon previous results and we aim to further the
understanding of the function and importance of TRPV5. Through these studies, we
have determined high resolution structures of TRPV5 both with and without ligands and
have reported the highest resolution structure of TRPV5 to date at 2.6 Å resolution.
Additionally, we have solved structures of TRPV5 in complex with PI(4,5)P2 to 2.8 Å and
3.4 Å resolution, compared with the previous structure at 4.0 Å resolution16. These highresolution structures provide a solid structural basis for channel opening upon PI(4,5)P2
binding. This information may be applicable to other TRP channels as well. Also,
because higher resolution models can provide better starting models for computational
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studies, molecular dynamic simulations and structure-based virtual screening may also
benefit from the improved resolution as well as the new states of the channel.
These studies also proposed mechanisms of channel gating for two modulators
of TRPV5. Regarding the mechanism of PKA activation, our structures confirmed that
there was little structural change upon phosphorylation, and that the mechanism is likely
by preventing CaM binding and inactivation24,30. For the mechanisms of TRPV5 inhibition
by low pH, we found that salt bridge formation around the intracellular pH sensor drove
the channel into a more closed state. We found evidence that low pH may also cause
PI(4,5)P2 to dissociate from the channel, consistent with a recent computational model61.
Because TRPV5 and TRPV6 are very similar, they share many of the same modulators
including pH and PKA, and our results from our studies on TRPV5 may be relevant to
understand the mechanisms of TRPV6 gating.

3.3 Future Studies
There are still many questions remaining regarding TRPV5’s biological functions
still to be answered. For example, there are many more endogenous modulators of
TRPV5 that have been structurally studied. One of these, Klotho, a known anti-aging
type 1 membrane protein, has been shown to regulate TRPV5 through alteration of Nglycosylation82. These glycosylation sites have not yet been structurally studied and
impacts on channel structure could be of interest. Interestingly, another study claimed
that soluble α-klotho may directly bind TRPV5 and form a complex together with
galectin-183. Capturing this multi-protein complex would be insightful to TRPV5 function
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and trafficking in the cell. It is thought that these interactions prevent diabetes-mediated
endocytosis of TRPV5 and would therefore be a good target for future therapeutics.
Another protein that could be of interest is claudin-16. Claudin-16 is also
controlled by PKA phosphorylation which mediates its trafficking from the tight junctions
to the apical membrane where TRPV5 is located. Phosphorylated claudin-16 is shown to
increase TRPV5 membrane abundance and directly interact with it at the apical
membrane84. Further studies with claudin-16 may broaden the understanding of the full
role that PKA plays in TRPV5 and calcium reabsorption. Dysfunction of claudin-16 has
also

been associated

with familial

hypomagnesemia

with hypercalciuria

and

nephrocalcinosis (FHHNC), making it a disease relevant target that could benefit from
additional study. It would be interesting to determine more about the TRPV5 to claudin16 interaction.
Our lab has previously solved the structure of TRPV5 with inhibitor Econazole41.
Then using structure-based virtual screening, we developed novel, specific inhibitors of
TRPV543. However, it would also be very interesting and useful to develop activators of
TRPV5 as well. Using the new structures of TRPV5 bound to PI(4,5)P2, and similar
methods, new activators of TRPV5 could be developed. A specific activator would be
incredibly valued for its potential therapeutic benefits for kidney stone disease.

3.4 Conclusions and Remarks
Overall, TRPV5 is a very important protein for the reabsorption of calcium in the
body. It must be carefully regulated in order to maintain calcium homeostasis. I have
worked to characterize several endogenous modulators to better understand the
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fundamental mechanisms of TRPV5 gating using a structural approach. The structures
generated in these experiments agree with functional data and will certainly be useful for
further studies.
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